Madame Bioscience PCL (BKK:MADAME)

Madame Bioscience PCL Cash Flow Statement

Financials in millions THB. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-141.06	45.77	-331.63	-405.81	-422.31	-152.43
Depreciation & Amortization	87.89	96.94	90.75	107.02	90.33	93.68
Other Amortization	0.14	0.14	0.81	0.81	1.65	1.87
Loss (Gain) From Sale of Assets	76.84	80.74	2.7	-0.31	22.69	-14.46
Asset Writedown & Restructuring Costs	13.73	17.07	-1.31	198.82	26.99	127.86
Loss (Gain) From Sale of Investments	-	-	98.01	-	-	-
Provision & Write-off of Bad Debts	67.54	67.96	0.13	-0.09	-1.82	2.54
Other Operating Activities	5.17	-316.08	279.56	53.4	44.07	-19.27
Change in Accounts Receivable	-110.89	106.8	-4.34	-28.24	74.36	-76.52
Change in Inventory	37.4	95.48	72.63	50.92	95.04	-122.61
Change in Accounts Payable	-28.88	-156.89	13.64	71.79	-79.54	139.08
Change in Other Net Operating Assets	24.43	-3.26	6.06	23.68	-16.12	-77.85
Operating Cash Flow	37.35	39.72	227.01	71.98	-163.44	-98.48
Operating Cash Flow Growth	-59.39%	-82.50%	215.36%	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-47.3	-41.49	-15.39	-39.61	-144.02	-206.38
Sale of Property, Plant & Equipment	2.83	4.39	1.41	6.74	0.17	1.41
Cash Acquisitions	-	-160.46	-	-	-484.08	-
Divestitures	-	-	-	-	-	84.43
Investment in Securities	-0.3	-	-	-	-	-
Other Investing Activities	14.7	17.45	1.73	-84.9	-27.78	-
Investing Cash Flow	-30.07	-180.1	-12.25	-117.77	-655.71	-120.53

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	389.29	-	-	58.43	628.62
Long-Term Debt Issued	-	301.75	9.89	-	386.11	135.08
Total Debt Issued	677.38	691.04	9.89	-	444.54	763.7
Short-Term Debt Repaid	-	-437.45	-1.96	-34.86	-	-598.89
Long-Term Debt Repaid	-	-275.45	-205.73	-83.49	-21.77	-47.33
Total Debt Repaid	-693.77	-712.91	-207.69	-118.36	-21.77	-646.22
Net Debt Issued (Repaid)	-16.39	-21.87	-197.8	-118.36	422.76	117.48
Issuance of Common Stock	116.16	116.16	73.83	-	646.27	103.28
Other Financing Activities	-21.27	136.16	-44.94	-54.22	-38.45	-60.31
Financing Cash Flow	78.5	230.45	-168.9	-172.57	1,031	160.45

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	85.79	90.07	45.85	-218.35	211.43	-58.56

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	-9.94	-1.77	211.62	32.37	-307.46	-304.86
Free Cash Flow Growth	-	-	553.65%	-	-	-
Free Cash Flow Margin	-0.63%	-0.12%	9.97%	1.41%	-13.80%	-16.37%
Free Cash Flow Per Share	-0.01	-0.00	0.34	0.05	-0.51	-0.76
Levered Free Cash Flow	-154.13	41.08	184.59	50.55	-216.02	-315.95
Unlevered Free Cash Flow	-140.35	61.52	216.42	88.74	-189.69	-309.35

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	21.27	37.76	44.94	54.22	38.45	10.31
Cash Income Tax Paid	1.2	2.68	1.15	0.83	14.46	3.98
Change in Working Capital	-77.93	42.14	87.98	118.15	73.73	-137.9

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error